MONTREAL, QUEBEC--(Marketwire - April 08, 2009) - Heart Health, Inc. (PINK SHEETS: HHEL) is pleased to announce that the Company has paid its semiannual dividends on its Series B Convertible Preferred Stock in cash. The payments, prorated for the number of days the investment was held, were paid on April 1, 2009 and are set to be paid again on October 1, 2009, and represent an 8% annual cash return on the Series B Preferred shares. The Company has the option to pay its dividends in stock or in cash and decided last October and this April to pay the dividend in cash.
“The Company still feels that their shares are undervalued and decided to pay a cash dividend instead of using our stock. We are excited about our current efforts to increase shareholder value. We believe we are making great progress and are very close to having our production prototype ready to begin manufacturing next quarter,” stated Michael Kron, Chairman and CEO of Heart Health, Inc.
Heart Health, Inc. recently announced that it is currently finishing the Financial Statements for 2007 and 2008, which the Company will soon be posting on www.PinkSheets.com. This is the first step in moving the Company’s stock symbol to the status of Current Information on PinkSheets
About Heart Health, Inc.:
Heart Health, Inc. is focused on the development and marketing of innovative, cardiovascular medical device products. The Company intends to revolutionize the way in which people monitor the health of their hearts using newly acquired products such as the Heart Health Monitor.
Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Contacts:
Heart Health, Inc.
Investor Relations
1-866-THE-APPL(E)